MDGL: MADRIGAL PHARMACEUTICALS, INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-29 | Fell below 5% | BlackRock, Inc. | 4.60% | SEC |
Institutional ownership (Q2 2026)
416 institutions reported holding $12.39B of MADRIGAL PHARMACEUTICALS, INC. on Form 13F (381 the quarter before). 76 opened a new position and 41 sold out. Shares held by institutions: same.
| Largest holders | Shares | Value |
|---|---|---|
| BAKER BROS. ADVISORS LP | 2,143,131 | $1.15B |
| RTW INVESTMENTS, LP | 1,993,687 | $1.07B |
| Jupiter Topco LLC | 1,936,099 | $1.04B |
| Avoro Capital Advisors LLC | 1,833,333 | $984.41M |
| PAULSON & CO. INC. | 1,340,020 | $719.52M |
| BlackRock, Inc. | 1,200,770 | $644.75M |
| VANGUARD CAPITAL MANAGEMENT LLC | 835,668 | $448.71M |
| WELLINGTON MANAGEMENT GROUP LLP | 825,714 | $443.37M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 781,731 | $419.75M |
| STATE STREET CORP | 527,057 | $283.00M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.